X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
human necessities (49) 49
index medicus (42) 42
hygiene (38) 38
medical or veterinary science (38) 38
preparations for medical, dental, or toilet purposes (38) 38
humans (37) 37
chemistry (34) 34
metallurgy (34) 34
organic chemistry (34) 34
peptides (33) 33
cancer (26) 26
oncology (21) 21
physics (21) 21
microbiology (20) 20
beer (19) 19
biochemistry (19) 19
enzymes (19) 19
enzymology (19) 19
investigating or analysing materials by determining theirchemical or physical properties (19) 19
measuring (19) 19
mutation or genetic engineering (19) 19
spirits (19) 19
testing (19) 19
vinegar (19) 19
wine (19) 19
animals (17) 17
male (17) 17
specific therapeutic activity of chemical compounds ormedicinal preparations (16) 16
cell line, tumor (15) 15
cell biology (13) 13
article (12) 12
mice (12) 12
tumors (12) 12
dairy products, e.g. milk, butter, cheese (11) 11
expression (11) 11
foods or foodstuffs (11) 11
foods, foodstuffs, or non-alcoholic beverages, not covered bysubclasses a23b - a23j (11) 11
indexing scheme relating to foods, foodstuffs or non-alcoholicbeverages (11) 11
making thereof (11) 11
milk or cheese substitutes (11) 11
phosphatide compositions for foodstuffs (11) 11
preservation of foods or foodstuffs, in general (11) 11
protein compositions for foodstuffs (11) 11
their preparation or treatment, e.g. cooking, modification ofnutritive qualities, physical treatment (11) 11
their treatment, not covered by other classes (11) 11
working-up proteins for foodstuffs (11) 11
analysis (9) 9
apoptosis (9) 9
chemotherapy (9) 9
proteins (9) 9
breast-cancer (8) 8
female (8) 8
adult (7) 7
care and treatment (7) 7
malaria (7) 7
patients (7) 7
research (7) 7
surveillance (7) 7
treatment outcome (7) 7
biochemistry & molecular biology (6) 6
bladder cancer (6) 6
chondroitin sulfate (6) 6
metastasis (6) 6
middle aged (6) 6
neoplasm staging (6) 6
oxidative stress (6) 6
reactive oxygen species - metabolism (6) 6
testicular cancer (6) 6
urology (6) 6
abstracts (5) 5
antigens, protozoan - metabolism (5) 5
chondroitin sulfates - metabolism (5) 5
clinical trials (5) 5
gene (5) 5
gene expression (5) 5
growth (5) 5
health aspects (5) 5
multidisciplinary sciences (5) 5
orchiectomy (5) 5
protein (5) 5
protein binding (5) 5
register (5) 5
seminoma (5) 5
testicular neoplasms (5) 5
testicular neoplasms - pathology (5) 5
ubiquitin-protein ligases - metabolism (5) 5
urinary bladder neoplasms - pathology (5) 5
urology & nephrology (5) 5
xenograft model antitumor assays (5) 5
young adult (5) 5
abridged index medicus (4) 4
adolescent (4) 4
aged (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
biology (4) 4
cisplatin (4) 4
denmark - epidemiology (4) 4
developmental biology (4) 4
disease-free survival (4) 4
hela cells (4) 4
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (147) 147
French (16) 16
German (10) 10
Danish (7) 7
Chinese (3) 3
Spanish (3) 3
Portuguese (2) 2
Japanese (1) 1
Korean (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, ISSN 1470-2045, 2015, Volume 16, Issue 1, pp. 76 - 86
Summary Background Patients with muscle-invasive urothelial carcinoma of the bladder have poor survival after cystectomy. The EORTC 30994 trial aimed to... 
Hematology, Oncology and Palliative Medicine | ADJUVANT CHEMOTHERAPY | PLUS CISPLATIN | METAANALYSIS | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | DOXORUBICIN | METHOTREXATE | VINBLASTINE | CANCER | GEMCITABINE | Lymph Node Excision | Cystectomy - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carcinoma - mortality | Male | Vinblastine - administration & dosage | Cystectomy - adverse effects | Urothelium - pathology | Cisplatin - administration & dosage | Time Factors | Urinary Bladder Neoplasms - pathology | Female | Chemotherapy, Adjuvant | Carcinoma - pathology | Doxorubicin - administration & dosage | Carcinoma - drug therapy | Urinary Bladder Neoplasms - mortality | Drug Administration Schedule | Time-to-Treatment | Carcinoma - surgery | Deoxycytidine - administration & dosage | Europe | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Urinary Bladder Neoplasms - drug therapy | Urinary Bladder Neoplasms - surgery | Canada | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Methotrexate - administration & dosage | Urothelium - surgery | Neoplasm Staging | Urothelium - drug effects | Deoxycytidine - analogs & derivatives | Care and treatment | Chemotherapy | Carcinoma | Hospitals | Cancer
Journal Article
Journal Article
Nature Structural and Molecular Biology, ISSN 1545-9993, 08/2012, Volume 19, Issue 8, pp. 803 - 810
Journal Article
Chemical Reviews, ISSN 0009-2665, 09/2017, Volume 117, Issue 17, p. 11337
Plant cell walls are composed of an intricate network of polysaccharides and proteins that varies during the developmental stages of the cell. This makes it... 
Carbohydrates | Plants (botany) | Algae | Cellulose | Biosynthesis | Pectin | Oligosaccharides | Cell adhesion & migration | Proteins | Polysaccharides | Developmental stages | Chemists | Cell adhesion | Computer networks | Flowers & plants | Chemical synthesis | Saccharides
Journal Article
Cancer, ISSN 0008-543X, 10/2017, Volume 123, Issue 19, pp. 3807 - 3815
BACKGROUND Programmed death 1 (PD‐1) signaling in the tumor microenvironment dampens immune responses to cancer, and blocking this axis induces antitumor... 
checkpoint | neuroblastoma | tumor‐infiltrating lymphocytes | programmed death 1/programmed death 1 ligand (PD‐1/PD‐L1) blockade | immunotherapy | pediatric cancer | tumor-infiltrating lymphocytes | programmed death 1/programmed death 1 ligand (PD-1/PD-L1) blockade | ONCOLOGY-GROUP | PD-L1 EXPRESSION | INFILTRATING LYMPHOCYTES | WILMS-TUMOR | UNTREATED MELANOMA | LUNG-CANCER | ONCOLOGY | NEUROECTODERMAL TUMOR | ADULT GLIOBLASTOMA | T-CELLS | CLINICAL-SIGNIFICANCE | Immunohistochemistry | Bone Neoplasms - mortality | Tissue Array Analysis | Humans | Sarcoma, Ewing - pathology | Rhabdomyosarcoma - pathology | Neuroblastoma - mortality | Osteosarcoma - chemistry | Macrophages | Bone Neoplasms - pathology | Burkitt Lymphoma - pathology | Neoplasms - chemistry | Lymphocytes, Tumor-Infiltrating | Burkitt Lymphoma - immunology | Neuroblastoma - immunology | Bone Neoplasms - chemistry | Glioblastoma - chemistry | Child | Neuroblastoma - pathology | Rhabdomyosarcoma - immunology | Sarcoma, Ewing - chemistry | Neuroblastoma - chemistry | Neoplasms - mortality | Bone Neoplasms - immunology | Burkitt Lymphoma - chemistry | Sarcoma, Ewing - immunology | Osteosarcoma - immunology | Glioblastoma - immunology | Neoplasms - immunology | Glioblastoma - pathology | Neoplasm Proteins - analysis | B7-H1 Antigen - analysis | Rhabdomyosarcoma - chemistry | Neoplasms - pathology | Osteosarcoma - pathology | Chemotherapy | Usage | Care and treatment | Diagnosis | Research | Gene expression | Cancer in children | Cancer | Pediatrics | Parkinson's disease | PD-1 protein | Glioblastoma | Neuroblastoma | Tissues | Anticancer properties | Metastases | Lymphocytes | Children | Movement disorders | Immune system | Immune response | Neurodegenerative diseases | Tumor cells | Mortality | Patients | Survival | Glioblastoma multiforme | Lymphoma | Burkitt's lymphoma | PD-L1 protein | Biomarkers | Ligands | Death | Antitumor activity | Infiltration | Lymphomas | Diagnostic systems | Tumors | Apoptosis
Journal Article
Journal of Membrane Science, ISSN 0376-7388, 02/2020, Volume 595, p. 117515
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 2985 - 2985
Journal Article
Nature Communications, ISSN 2041-1723, 2013, Volume 4, Issue 1, p. 2180
Journal Article
Molecular Cancer Research, ISSN 1541-7786, 04/2017, Volume 15, Issue 4 Supplement, pp. B15 - B15
Journal Article
Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 3279 - 13
Journal Article